First AD

Second AD

Gastrointestinal Cancer

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

News

® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses. 

Gaining Ground: Expanding Options for Advanced HCC

OncLive News Network®

The panel shares insight as to which patients might be candidates for curative therapies such as embolization techniques and liver transplant.

Review of Curative Treatment Strategies for HCC

Overview of Hepatocellular Carcinoma Risk Factors

Child-Pugh Scoring System and Liver Function Assessment

Therapy for Locally Advanced HCC

The Advent of Systemic Therapy for HCC

Immune Checkpoint Inhibitors in HCC

Combination Therapy with Immune Checkpoint Inhibitors for HCC

IMbrave-150 and HIMALAYA: Clinical Trials of Immune Checkpoint Inhibitor Combinations in HCC

Immune Checkpoint Inhibitors and Their Effects on Liver Function

Real-World Evidence on Use of Immune Checkpoint Inhibitor Combinations and Clinical Trial Endpoints

Novel Strategies: Combining Systemic and Local Therapies

HCC International Clinical Trials